Conservative Management of Severe Medication-Related Osteonecrosis of the Jaw With Pathological Fracture

被引:1
|
作者
Varidel, Alistair [1 ]
Wong, Eva [1 ]
机构
[1] Crown Princess Mary Canc Ctr, Head & Neck Canc Serv, Sydney, NSW, Australia
关键词
Conservative; management; MRONJ; pathological fracture; BISPHOSPHONATE-RELATED OSTEONECROSIS; SURGICAL RESECTION; POSITION PAPER; RISK-FACTORS; RECONSTRUCTION;
D O I
10.1097/SCS.0000000000008222
中图分类号
R61 [外科手术学];
学科分类号
摘要
Medication-related osteonecrosis of the jaw (MRONJ) is a well-known risk following dental extraction in patients taking certain medications. Pathological fracture secondary to MRONJ often requires complex operative intervention. This case demonstrates the conservative management of pathological fracture secondary to MRONJ in a patient with multiple comorbidities. The patient developed MRONJ with pathological fracture following extraction of the mandibular second molar. The patient presented with significant surgical risk factors, having hypertension and a recent stroke, causing dense left hemiparesis, subsequently resulting in transition to high-level nursing care. Given the high risk of reconstructive surgery, nonoperative management was undertaken. Following a course of long-term antibiotics with resolution of signs of infection, the case was managed conservatively with chlorhexidine-based mouthwash and soft diet. With routine clinico-radiographic assessment and optimal oral health care, the pathological fracture did not require operative intervention. Healing progressed well with no clinical complications and radiographic evidence of good healing at 6- and 12-month follow-up on orthopantomogram. A role for conservative management of pathological fractures secondary to MRONJ yet exists, especially in the elderly population. This case highlights the importance of developing treatment plans based on individual patient context and clinical assessment.
引用
收藏
页码:E329 / E333
页数:5
相关论文
共 50 条
  • [41] Patients' osteometabolic control improves the management of medication-related osteonecrosis of the jaw
    Colapinto, Gianluca
    Volpi, Raffaele
    Forino, Giovanni
    Tricarico, Vito
    De Benedittis, Michele
    Cortelazzi, Roberto
    Testori, Tiziano
    Del Fabbro, Massimo
    [J]. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2018, 125 (02): : 147 - 156
  • [42] COMMENT ON: MEDICATION-RELATED OSTEONECROSIS OF THE JAW IN OSTEOPOROTIC PATIENTS: PREVENTION AND MANAGEMENT
    Toh, Choon Lai
    Dutton, Andrew
    [J]. SINGAPORE MEDICAL JOURNAL, 2018, 59 (05) : 287 - 287
  • [43] COMMENT ON: MEDICATION-RELATED OSTEONECROSIS OF THE JAW IN OSTEOPOROTIC PATIENTS: PREVENTION AND MANAGEMENT
    Ngeow, Wei Cheong
    Chai, Wen Lin
    [J]. SINGAPORE MEDICAL JOURNAL, 2019, 60 (01) : 52 - 52
  • [45] Cast-cap splint in the management of medication-related osteonecrosis of the jaw
    Markose, G.
    Graham, R. M.
    [J]. BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 2017, 55 (04): : 416 - 417
  • [46] Medication-related osteonecrosis of the jaw: evolving research for multimodality medical management
    Ali Abdolrahmani
    Joel B. Epstein
    Firoozeh Samim
    [J]. Supportive Care in Cancer, 2024, 32
  • [47] Medication-related osteonecrosis of the jaw: evolving research for multimodality medical management
    Abdolrahmani, Ali
    Epstein, Joel B.
    Samim, Firoozeh
    [J]. SUPPORTIVE CARE IN CANCER, 2024, 32 (04)
  • [48] Comparison of the Effectiveness of Conservative and Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: a Systematic Review
    Seluki, Rial
    Seluki, Moshe
    Vaitkeviciene, Inga
    Jagelaviciene, Egle
    [J]. JOMR-JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH, 2023, 14 (04):
  • [49] Impaired Callus Formation in Pathological Mandibular Fractures in Medication-Related Osteonecrosis of the Jaw and Osteoradionecrosis
    Van Camp, Nathalie
    Verhelst, Pieter-Jan
    Nicot, Romain
    Ferri, Joel
    Politis, Constantinus
    [J]. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2021, 79 (09) : 1892 - 1901
  • [50] Treatment of medication-related osteonecrosis of the jaw with cell therapy
    Bouland, Cyril Lucien
    Javadian, Rokneddine
    Gilis, Sarah
    Yanni, Antoine
    Le Clercq, Maxime
    Mestrallet, Pierre
    Kampouridis, Stelianos
    Bron, Dominique
    Lalmand, Martin
    Vanden Eynden, Xavier
    Boutremans, Edward
    Dequanter, Didier
    Loeb, Isabelle
    Philippart, Pierre
    Lagneaux, Laurence
    Meuleman, Nathalie
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12